126 related articles for article (PubMed ID: 37753543)
1. Association between weight loss and death in patients with malignant melanoma: A retrospective study of 28 cases.
Tanaka A; Miyazawa H; Yanagi T; Maeda T; Kitamura S; Ujiie H
J Dermatol; 2024 Mar; 51(3):463-466. PubMed ID: 37753543
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
[TBL] [Abstract][Full Text] [Related]
4. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
[TBL] [Abstract][Full Text] [Related]
6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
7. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
9. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
Tas F; Erturk K
Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
[TBL] [Abstract][Full Text] [Related]
10. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
11. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.
Tas F; Oguz H; Argon A; Duranyildiz D; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(3):241-6. PubMed ID: 16110135
[TBL] [Abstract][Full Text] [Related]
12. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
13. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
[TBL] [Abstract][Full Text] [Related]
14. Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy.
Weide B; Richter S; Büttner P; Leiter U; Forschner A; Bauer J; Held L; Eigentler TK; Meier F; Garbe C
PLoS One; 2013; 8(11):e81624. PubMed ID: 24312329
[TBL] [Abstract][Full Text] [Related]
15. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
17. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease.
Kretschmer L; Hilgers R; Möhrle M; Balda BR; Breuninger H; Konz B; Kunte C; Marsch WC; Neumann C; Starz H
Eur J Cancer; 2004 Jan; 40(2):212-8. PubMed ID: 14728935
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.
Weide B; Faller C; Büttner P; Pflugfelder A; Leiter U; Eigentler TK; Bauer J; Forschner A; Meier F; Garbe C
PLoS One; 2013; 8(4):e63137. PubMed ID: 23638183
[TBL] [Abstract][Full Text] [Related]
19. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Lactate Dehydrogenase in Patients with Melanoma Treated with Pembrolizumab.
Popović A; Petković I; Dimitrijevic A; Jović A
Acta Dermatovenerol Croat; 2023 Nov; 31(2):86-91. PubMed ID: 38006368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
